An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.
If the blood test - from California-based biotechnology company Freenome - was approved for market, it would be one of the ...
This method will brings us closer to a potential blood test that could help doctors identify which IBD patients are most at risk ...
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an agreement with the Abu Dhabi ...
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop the disease, research has shown. People with inflammatory bowel ...